1. Intratumoral Foxp3⁺RORγt⁺ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients

   • Yuchao Fei
   • Yifan Cao
   • Weijuan Zhang

   Original Article 12 May 2021 Pages: 1 - 11

   

2. Reduced frequency of cytotoxic CD56^dim CD16⁺ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma

   • Elena Pánisová
   • Anna Lünemann
   • Tarik Azzi

   Original Article Open access 15 May 2021 Pages: 13 - 24

   

3. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma

   • Lin Sun
   • Luwen Mu
   • Jin Wang

   Original Article 16 May 2021 Pages: 25 - 38

   

4. Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature

   • Guoxing Zhao
   • Runhong Wei
   • Zhi Cheng

   Original Article Open access 18 May 2021 Pages: 39 - 44

   

5. Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer

   • Ina Valeria Zurlo
   • Mattia Schino
   • Maurizio Martini

   Original Article Open access 19 May 2021 Pages: 45 - 55

   

6. CD74⁺ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma

   • Nan Xiao
   • Kangshuai Li
   • Hui-Chuan Sun

   Original Article 19 May 2021 Pages: 57 - 69

   

7. SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cells

   • Meriem Bahri
   • Sareetha Kailayangiri
   • Stéphane Birklé

   Original Article 22 May 2021 Pages: 71 - 83

   

8. Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer

   • Victor M. Schuettfort
   • Benjamin Pradere
   • Shahrokh F. Shariat

   Original Article Open access 23 May 2021 Pages: 85 - 95

   

9. Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice

   • Anna Wasiuk
   • Jeff Weidlick
   • Li-Zhen He

   Original Article Open access 24 May 2021 Pages: 97 - 109

   

10. PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients

    • Yanni Wang
    • Huan Chen
    • Lin Shen

    Original Article Open access 24 May 2021 Pages: 111 - 120

    

11. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma

    • Lulu Liu
    • Ruyi Zhang
    • Xuanwen Bao

    Original Article 24 May 2021 Pages: 121 - 136

    

12. CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1⁺ CD8⁺ T cells

    • Takayoshi Yamauchi
    • Toshifumi Hoki
    • Fumito Ito

    Original Article 26 May 2021 Pages: 137 - 151

    

13. Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance

    • Rachelle Tibbetts
    • Kee Kiat Yeo
    • Shahab Asgharzadeh

    Original Article 27 May 2021 Pages: 153 - 164

    

14. Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30

    • Savannah E. Butler
    • Rachel A. Brog
    • Margaret E. Ackerman

    Original Article 27 May 2021 Pages: 165 - 176

    

15. STAT3 is over-activated within CD163^pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS

    • Morten N. Andersen
    • Niels F. Andersen
    • Holger J. Møller

    Original Article 01 June 2021 Pages: 177 - 187

    

16. Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy

    • Chisato Yokota
    • Naoki Kagawa
    • Naoya Hashimoto

    Original Article 05 June 2021 Pages: 189 - 201

    

17. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer

    • Masato Karayama
    • Naoki Inui
    • Takafumi Suda

    Original Article Open access 05 June 2021 Pages: 203 - 217

    

18. ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC

    • Shiqi Mao
    • Fei Zhou
    • Shengxiang Ren

    Original Article 07 June 2021 Pages: 219 - 228

    

19. Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma

    • Wataru Fukuokaya
    • Takahiro Kimura
    • Shin Egawa

    Original Article 08 June 2021 Pages: 229 - 236